A detailed history of Peapack Gladstone Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 209,463 shares of ABBV stock, worth $37.7 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
209,463
Previous 198,766 5.38%
Holding current value
$37.7 Million
Previous $34.1 Million 21.33%
% of portfolio
0.6%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 26, 2024

BUY
$163.84 - $199.33 $1.75 Million - $2.13 Million
10,697 Added 5.38%
209,463 $41.4 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $49,997 - $58,385
323 Added 0.16%
198,766 $34.1 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $110,115 - $125,466
-689 Reduced 0.35%
198,443 $36.1 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $179,568 - $202,235
1,305 Added 0.66%
199,132 $30.9 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $241,397 - $279,452
-1,807 Reduced 0.91%
197,827 $29.5 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $510,296 - $635,029
3,851 Added 1.97%
199,634 $26.9 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $195,078 - $224,662
-1,349 Reduced 0.68%
195,783 $31.2 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $634,151 - $760,513
4,585 Added 2.38%
197,132 $31.9 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $3.27 Million - $3.75 Million
-24,385 Reduced 11.24%
192,547 $25.8 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $18,028 - $22,919
-131 Reduced 0.06%
216,932 $33.2 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $2.38 Million - $2.95 Million
18,037 Added 9.06%
217,063 $35.2 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $87,018 - $110,103
810 Added 0.41%
199,026 $26.9 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.78 Million - $2.02 Million
16,694 Added 9.2%
198,216 $21.4 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $346,772 - $386,324
3,296 Added 1.85%
181,522 $20.4 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $1.6 Million - $1.76 Million
15,641 Added 9.62%
178,226 $19.3 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.11 Million - $1.5 Million
13,827 Added 9.29%
162,585 $17.4 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $221,561 - $260,040
2,579 Added 1.76%
148,758 $13 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $11,445 - $15,316
-156 Reduced 0.11%
146,179 $14.4 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $206,271 - $312,732
-3,198 Reduced 2.14%
146,335 $11.1 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $139,571 - $174,633
-1,935 Reduced 1.28%
149,533 $13.2 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $309,798 - $372,466
-4,919 Reduced 3.15%
151,468 $11.5 Million
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $96,447 - $123,282
-1,468 Reduced 0.93%
156,387 $11.4 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $137,154 - $161,424
1,778 Added 1.14%
157,855 $12.7 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $114,828 - $141,614
1,475 Added 0.95%
156,077 $14.4 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $306,028 - $340,207
-3,442 Reduced 2.18%
154,602 $14.6 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $53,868 - $63,738
600 Added 0.38%
158,044 $14.6 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $328,751 - $440,229
-3,573 Reduced 2.22%
157,444 $0
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $126,996 - $139,261
-1,418 Reduced 0.87%
161,017 $0
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $568,858 - $726,607
-8,144 Reduced 4.77%
162,435 $0
Q2 2017

Aug 14, 2017

BUY
N/A
170,579
170,579 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.